PL4013502T3 - Sposób otrzymywania pochodnej pirymidyno-diazepiny - Google Patents
Sposób otrzymywania pochodnej pirymidyno-diazepinyInfo
- Publication number
- PL4013502T3 PL4013502T3 PL20758301.4T PL20758301T PL4013502T3 PL 4013502 T3 PL4013502 T3 PL 4013502T3 PL 20758301 T PL20758301 T PL 20758301T PL 4013502 T3 PL4013502 T3 PL 4013502T3
- Authority
- PL
- Poland
- Prior art keywords
- pyrimidino
- preparation
- diazepine derivative
- diazepine
- derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1911796.9A GB201911796D0 (en) | 2019-08-16 | 2019-08-16 | Process |
| GBGB2008591.6A GB202008591D0 (en) | 2020-06-08 | 2020-06-08 | Process |
| PCT/GB2020/051950 WO2021032958A1 (en) | 2019-08-16 | 2020-08-14 | Process for the preparation of a pyrimidino-diazepine derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4013502T3 true PL4013502T3 (pl) | 2026-04-20 |
Family
ID=72148172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20758301.4T PL4013502T3 (pl) | 2019-08-16 | 2020-08-14 | Sposób otrzymywania pochodnej pirymidyno-diazepiny |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12570660B2 (pl) |
| EP (1) | EP4013502B8 (pl) |
| JP (2) | JP2022544583A (pl) |
| KR (1) | KR20220047823A (pl) |
| CN (1) | CN114269727A (pl) |
| AU (1) | AU2020333225B2 (pl) |
| CA (1) | CA3145287A1 (pl) |
| DK (1) | DK4013502T3 (pl) |
| ES (1) | ES3047933T3 (pl) |
| PL (1) | PL4013502T3 (pl) |
| WO (1) | WO2021032958A1 (pl) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0230089D0 (en) | 2002-12-24 | 2003-01-29 | Astrazeneca Ab | Therapeutic agents |
| GB0302220D0 (en) | 2003-01-30 | 2003-03-05 | Cyclacel Ltd | Use |
| UY29149A1 (es) | 2004-10-07 | 2006-05-31 | Boehringer Ingelheim Int | Tiazolil-dihidro-indazoles |
| JP2009523820A (ja) * | 2006-01-23 | 2009-06-25 | アミラ ファーマシューティカルス，インコーポレーテッド | ５−リポキシゲナーゼの三環系抑制剤 |
| CN101821245B (zh) * | 2007-08-14 | 2012-10-10 | 贝林格尔·英格海姆国际有限公司 | 化合物 |
| EP2205603B1 (en) * | 2007-09-28 | 2014-01-15 | Cyclacel Limited | Pyrimidine derivatives as protein kinase inhibitors |
| WO2010025073A1 (en) | 2008-08-28 | 2010-03-04 | Takeda Pharmaceutical Company Limited | Dihydroimidazo [ 1, 5-f] pteridines as polo-like kinase inhibitors |
| UA107360C2 (en) | 2009-08-05 | 2014-12-25 | Biogen Idec Inc | Bicyclic aryl sphingosine 1-phosphate analogs |
| CN102020643A (zh) * | 2009-09-22 | 2011-04-20 | 上海恒瑞医药有限公司 | 二氢喋啶酮类衍生物、其制备方法及其在医药上的应用 |
| US9193710B2 (en) | 2011-08-29 | 2015-11-24 | Sanford-Burnham Medical Research Institute | Benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof |
| MX360858B (es) * | 2012-07-30 | 2018-11-20 | Taisho Pharmaceutical Co Ltd | Compuesto heterocíclico que contiene nitrógeno parcialmente saturado. |
| AU2014337067B2 (en) * | 2013-10-18 | 2019-01-24 | Syros Pharmaceuticals, Inc. | Heteroaromatic compounds useful for the treatment of proliferative diseases |
| TW201718598A (zh) | 2015-08-27 | 2017-06-01 | 美國禮來大藥廠 | Ｅｚｈ２抑制劑 |
| EP3858835A1 (en) | 2016-07-01 | 2021-08-04 | G1 Therapeutics, Inc. | Pyrimidine-based antiproliferative agents |
| WO2019136244A1 (en) * | 2018-01-04 | 2019-07-11 | G1 Therapeutics, Inc. | Heterocyclic compounds for the treatment of abnormal cellular proliferation |
-
2020
- 2020-08-14 AU AU2020333225A patent/AU2020333225B2/en active Active
- 2020-08-14 ES ES20758301T patent/ES3047933T3/es active Active
- 2020-08-14 WO PCT/GB2020/051950 patent/WO2021032958A1/en not_active Ceased
- 2020-08-14 DK DK20758301.4T patent/DK4013502T3/da active
- 2020-08-14 PL PL20758301.4T patent/PL4013502T3/pl unknown
- 2020-08-14 US US17/634,693 patent/US12570660B2/en active Active
- 2020-08-14 CA CA3145287A patent/CA3145287A1/en active Pending
- 2020-08-14 EP EP20758301.4A patent/EP4013502B8/en active Active
- 2020-08-14 JP JP2022509581A patent/JP2022544583A/ja active Pending
- 2020-08-14 KR KR1020227008594A patent/KR20220047823A/ko active Pending
- 2020-08-14 CN CN202080057858.5A patent/CN114269727A/zh active Pending
-
2025
- 2025-07-03 JP JP2025113288A patent/JP2025143418A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4013502B1 (en) | 2025-09-10 |
| WO2021032958A1 (en) | 2021-02-25 |
| EP4013502A1 (en) | 2022-06-22 |
| AU2020333225A1 (en) | 2022-02-24 |
| CN114269727A (zh) | 2022-04-01 |
| JP2022544583A (ja) | 2022-10-19 |
| AU2020333225B2 (en) | 2026-04-23 |
| DK4013502T3 (da) | 2025-11-10 |
| CA3145287A1 (en) | 2021-02-25 |
| EP4013502B8 (en) | 2025-10-22 |
| JP2025143418A (ja) | 2025-10-01 |
| ES3047933T3 (en) | 2025-12-05 |
| US20220289755A1 (en) | 2022-09-15 |
| KR20220047823A (ko) | 2022-04-19 |
| US12570660B2 (en) | 2026-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276917A (en) | A process for the preparation of alubixivet | |
| IL267508B (en) | A process for the preparation of 2-pyridylethyl carboxamide derivatives | |
| GB2593352B (en) | Process for the preparation of 3alpha-hydroxy-5alpha-pregnan-20-one (brexanolone) | |
| SG11202103664WA (en) | Process for producing perfluoroalkyne compound | |
| IL289904A (en) | A process for preparing biphenylamines | |
| SG11202108238VA (en) | Process for the preparation of methionine | |
| IL285858A (en) | A process for making levoamphetamine | |
| LT3765440T (lt) | N-alkil-nitratoetilnitraminų gamybos būdas | |
| PL4077285T3 (pl) | Sposób wytwarzania fluralaneru | |
| IL275381A (en) | A process for the preparation of Crisborole | |
| SG11202011687RA (en) | Process for the preparation of cyclopropane compounds using diazo-com pounds | |
| IL285550A (en) | Process for preparing polyamides | |
| IL281254A (en) | A process for the preparation of lanbatinib | |
| IL286006A (en) | Process for preparing 4-amino-5-methylpyridone | |
| IL283633A (en) | A process for preparing a cyclic dinucleotide | |
| PL4037679T3 (pl) | Sposób wytwarzania walsartanu o wysokiej czystości | |
| IL276557A (en) | A process for making metformin | |
| PL3886605T3 (pl) | Proces przygotowania frakcji zbożowych | |
| GB201909178D0 (en) | Methods for preparing compounds | |
| PL3802529T3 (pl) | Sposób wytwarzania palbocyklibu | |
| PL3599256T3 (pl) | Sposób wytwarzania poliorganosiloksanów | |
| IL286054A (en) | A process for the preparation of a modified imidazoquinoline | |
| ZA202102159B (en) | Process for the preparation of a flavouring | |
| IL290215A (en) | A process for the preparation of crystalline form ii of sotagliflozin | |
| PL4013502T3 (pl) | Sposób otrzymywania pochodnej pirymidyno-diazepiny |